Adiponectin, alanine transaminase, physical activity, diastolic blood pressure and fat free mass were independently associated with hypermetabolism in subjects with NAFLD and T2DM. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.